Rank | Gene Set | Z-score |
---|---|---|
1 | detection of molecule of bacterial origin (GO:0032490) | 6.25794047 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.73512867 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.73512867 |
4 | modulation by symbiont of host immune response (GO:0052553) | 5.73512867 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.73512867 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.73512867 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.73512867 |
8 | L-phenylalanine catabolic process (GO:0006559) | 5.48654484 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.48654484 |
10 | cysteine metabolic process (GO:0006534) | 5.41720176 |
11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.31947409 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30593409 |
13 | L-phenylalanine metabolic process (GO:0006558) | 5.30593409 |
14 | urea metabolic process (GO:0019627) | 5.25895324 |
15 | urea cycle (GO:0000050) | 5.25895324 |
16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.21734569 |
17 | aromatic amino acid family catabolic process (GO:0009074) | 5.18930559 |
18 | macrophage activation involved in immune response (GO:0002281) | 5.01981285 |
19 | kynurenine metabolic process (GO:0070189) | 4.98809295 |
20 | homocysteine metabolic process (GO:0050667) | 4.93412652 |
21 | tryptophan catabolic process (GO:0006569) | 4.93364441 |
22 | indole-containing compound catabolic process (GO:0042436) | 4.93364441 |
23 | indolalkylamine catabolic process (GO:0046218) | 4.93364441 |
24 | sulfur amino acid catabolic process (GO:0000098) | 4.93191806 |
25 | serine family amino acid catabolic process (GO:0009071) | 4.83449193 |
26 | regulation of bile acid biosynthetic process (GO:0070857) | 4.82862841 |
27 | drug catabolic process (GO:0042737) | 4.81703596 |
28 | detection of external biotic stimulus (GO:0098581) | 4.80851375 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.73928582 |
30 | intestinal cholesterol absorption (GO:0030299) | 4.72066275 |
31 | detection of other organism (GO:0098543) | 4.66012904 |
32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65828963 |
33 | tryptophan metabolic process (GO:0006568) | 4.64958686 |
34 | bile acid and bile salt transport (GO:0015721) | 4.63163132 |
35 | cellular extravasation (GO:0045123) | 4.62984001 |
36 | intestinal absorption (GO:0050892) | 4.61045337 |
37 | regulation of cholesterol homeostasis (GO:2000188) | 4.57273752 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.56135518 |
39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51891831 |
40 | high-density lipoprotein particle remodeling (GO:0034375) | 4.51112996 |
41 | negative regulation of cholesterol transport (GO:0032375) | 4.42514954 |
42 | negative regulation of sterol transport (GO:0032372) | 4.42514954 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.41945165 |
44 | response to peptidoglycan (GO:0032494) | 4.41606814 |
45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.40838285 |
46 | negative regulation of cell killing (GO:0031342) | 4.40838285 |
47 | lysine catabolic process (GO:0006554) | 4.38516249 |
48 | lysine metabolic process (GO:0006553) | 4.38516249 |
49 | glyoxylate metabolic process (GO:0046487) | 4.38347799 |
50 | bile acid biosynthetic process (GO:0006699) | 4.35901136 |
51 | neutrophil activation involved in immune response (GO:0002283) | 4.31763362 |
52 | bile acid metabolic process (GO:0008206) | 4.26382552 |
53 | urate metabolic process (GO:0046415) | 4.25511694 |
54 | detection of biotic stimulus (GO:0009595) | 4.23565080 |
55 | microglial cell activation (GO:0001774) | 4.21353447 |
56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.18633366 |
57 | protein carboxylation (GO:0018214) | 4.18633366 |
58 | macrophage activation (GO:0042116) | 4.17546391 |
59 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13998072 |
60 | regulation of triglyceride catabolic process (GO:0010896) | 4.12335597 |
61 | regulation of protein activation cascade (GO:2000257) | 4.12061899 |
62 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.11055736 |
63 | phospholipid efflux (GO:0033700) | 4.10284898 |
64 | drug transmembrane transport (GO:0006855) | 4.06361708 |
65 | glycine metabolic process (GO:0006544) | 4.06176788 |
66 | serine family amino acid metabolic process (GO:0009069) | 4.05994829 |
67 | neutrophil mediated immunity (GO:0002446) | 4.01760066 |
68 | complement activation, alternative pathway (GO:0006957) | 4.00459316 |
69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.98989012 |
70 | acylglycerol homeostasis (GO:0055090) | 3.97369880 |
71 | triglyceride homeostasis (GO:0070328) | 3.97369880 |
72 | reverse cholesterol transport (GO:0043691) | 3.94647098 |
73 | regulation of complement activation (GO:0030449) | 3.89623481 |
74 | flavonoid metabolic process (GO:0009812) | 3.86930662 |
75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86190508 |
76 | response to host immune response (GO:0052572) | 3.86190508 |
77 | detection of bacterium (GO:0016045) | 3.84589466 |
78 | regulation of cholesterol esterification (GO:0010872) | 3.82945269 |
79 | negative regulation of fibrinolysis (GO:0051918) | 3.80267578 |
80 | cellular glucuronidation (GO:0052695) | 3.79696811 |
81 | protein-lipid complex remodeling (GO:0034368) | 3.79573192 |
82 | macromolecular complex remodeling (GO:0034367) | 3.79573192 |
83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.79573192 |
84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.78748803 |
85 | exogenous drug catabolic process (GO:0042738) | 3.76838018 |
86 | aromatic amino acid family metabolic process (GO:0009072) | 3.73493708 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 3.73086666 |
88 | cholesterol efflux (GO:0033344) | 3.72414099 |
89 | serine family amino acid biosynthetic process (GO:0009070) | 3.69750238 |
90 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.67611363 |
91 | glutamate metabolic process (GO:0006536) | 3.67152289 |
92 | response to host (GO:0075136) | 3.62886845 |
93 | response to host defenses (GO:0052200) | 3.62886845 |
94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.62886845 |
95 | cellular modified amino acid catabolic process (GO:0042219) | 3.61019301 |
96 | alpha-amino acid catabolic process (GO:1901606) | 3.60435016 |
97 | regulation of fibrinolysis (GO:0051917) | 3.59939950 |
98 | phospholipid homeostasis (GO:0055091) | 3.59597633 |
99 | lipoprotein metabolic process (GO:0042157) | 3.57787570 |
100 | sterol homeostasis (GO:0055092) | 3.57090685 |
101 | cholesterol homeostasis (GO:0042632) | 3.56141229 |
102 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51852115 |
103 | negative regulation of interleukin-12 production (GO:0032695) | 3.51670490 |
104 | tyrosine metabolic process (GO:0006570) | 3.51000310 |
105 | protein-lipid complex assembly (GO:0065005) | 3.50834499 |
106 | drug transport (GO:0015893) | 3.45354467 |
107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.45287124 |
108 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44220044 |
109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.41177113 |
110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.40999501 |
111 | plasma lipoprotein particle clearance (GO:0034381) | 3.40820888 |
112 | neutrophil activation (GO:0042119) | 3.40205665 |
113 | embryonic process involved in female pregnancy (GO:0060136) | 3.39113034 |
114 | ethanol oxidation (GO:0006069) | 3.39105292 |
115 | benzene-containing compound metabolic process (GO:0042537) | 3.38875596 |
116 | cellular ketone body metabolic process (GO:0046950) | 3.38833051 |
117 | cellular amino acid catabolic process (GO:0009063) | 3.38658156 |
118 | drug metabolic process (GO:0017144) | 3.38441865 |
119 | imidazole-containing compound metabolic process (GO:0052803) | 3.36825309 |
120 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32773401 |
121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32623969 |
122 | response to nitrosative stress (GO:0051409) | 3.30978734 |
123 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.30470974 |
124 | indolalkylamine metabolic process (GO:0006586) | 3.29149983 |
125 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28051863 |
126 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.27453502 |
127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23184009 |
128 | iron ion import (GO:0097286) | 3.23128092 |
129 | T-helper 1 type immune response (GO:0042088) | 3.21805702 |
130 | hormone catabolic process (GO:0042447) | 3.20009355 |
131 | positive regulation of lipid catabolic process (GO:0050996) | 3.18839190 |
132 | uronic acid metabolic process (GO:0006063) | 3.17825879 |
133 | glucuronate metabolic process (GO:0019585) | 3.17825879 |
134 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16507576 |
135 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16507576 |
136 | respiratory burst (GO:0045730) | 3.16045088 |
137 | cellular biogenic amine catabolic process (GO:0042402) | 3.14027651 |
138 | amine catabolic process (GO:0009310) | 3.14027651 |
139 | negative regulation of lipase activity (GO:0060192) | 3.13934927 |
140 | ethanol metabolic process (GO:0006067) | 3.13886517 |
141 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.13363253 |
142 | carnitine metabolic process (GO:0009437) | 3.12967472 |
143 | arginine metabolic process (GO:0006525) | 3.12639291 |
144 | short-chain fatty acid metabolic process (GO:0046459) | 3.12295936 |
145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10769541 |
146 | hypotonic response (GO:0006971) | 3.09829781 |
147 | granulocyte activation (GO:0036230) | 3.09450464 |
148 | lipid homeostasis (GO:0055088) | 3.04688591 |
149 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03535206 |
150 | germinal center formation (GO:0002467) | 3.03341618 |
151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03288767 |
152 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02861727 |
153 | fibrinolysis (GO:0042730) | 3.02689630 |
154 | histone H3-K36 demethylation (GO:0070544) | 3.02277460 |
155 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.01763246 |
156 | positive regulation of interferon-alpha production (GO:0032727) | 3.00806077 |
157 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96247836 |
158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.95402965 |
159 | response to muramyl dipeptide (GO:0032495) | 2.94878623 |
160 | myeloid cell activation involved in immune response (GO:0002275) | 2.94507587 |
161 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.93288742 |
162 | negative regulation of B cell mediated immunity (GO:0002713) | 2.93288742 |
163 | negative regulation of type 2 immune response (GO:0002829) | 2.86713902 |
164 | B cell receptor signaling pathway (GO:0050853) | 2.85576503 |
165 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84318161 |
166 | cellular response to ethanol (GO:0071361) | 2.84097301 |
167 | I-kappaB phosphorylation (GO:0007252) | 2.81005130 |
168 | regulation of leukocyte degranulation (GO:0043300) | 2.79830925 |
169 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78188063 |
170 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76637274 |
171 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76586086 |
172 | regulation of mast cell degranulation (GO:0043304) | 2.75514243 |
173 | regulation of interferon-alpha production (GO:0032647) | 2.74143682 |
174 | dendritic cell migration (GO:0036336) | 2.73081531 |
175 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72365230 |
176 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68767899 |
177 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67301299 |
178 | response to interleukin-15 (GO:0070672) | 2.66229252 |
179 | leukocyte aggregation (GO:0070486) | 2.65856768 |
180 | positive regulation of mast cell activation (GO:0033005) | 2.65382059 |
181 | regulation of macrophage cytokine production (GO:0010935) | 2.63762403 |
182 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62756702 |
183 | regulation of cellular amide metabolic process (GO:0034248) | 2.62646820 |
184 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60113818 |
185 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.58032123 |
186 | positive regulation of leukocyte degranulation (GO:0043302) | 2.57402116 |
187 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.55045335 |
188 | response to laminar fluid shear stress (GO:0034616) | 2.55032067 |
189 | neutrophil chemotaxis (GO:0030593) | 2.54702818 |
190 | positive regulation of macrophage cytokine production (GO:0060907) | 2.54594815 |
191 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52382383 |
192 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52382383 |
193 | dendritic cell chemotaxis (GO:0002407) | 2.52051540 |
194 | regulation of regulated secretory pathway (GO:1903305) | 2.50859766 |
195 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.48261771 |
196 | neutrophil migration (GO:1990266) | 2.47335743 |
197 | regulation of mast cell activation (GO:0033003) | 2.47054388 |
198 | response to vitamin D (GO:0033280) | 2.46390877 |
199 | hepatocyte apoptotic process (GO:0097284) | 2.45916204 |
200 | positive regulation of regulated secretory pathway (GO:1903307) | 2.44659513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.35412461 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17773761 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.56743606 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.96329298 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.68463321 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.47312796 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.46937060 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.43621444 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22597664 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19265556 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.16751240 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11519165 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02061301 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.93079891 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.92184855 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84376296 |
17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83968627 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58034078 |
19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.55057980 |
20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.43580767 |
21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.38364345 |
22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36761599 |
23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09966929 |
24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.07804217 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06299467 |
26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01933730 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.01456412 |
28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00536176 |
29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93244527 |
30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.88287314 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82763079 |
32 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.81710219 |
33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81228025 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79992454 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78475242 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.76562045 |
37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73000710 |
38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72020327 |
39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.63634149 |
40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62413295 |
41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62218126 |
42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61275714 |
43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57919468 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57302616 |
45 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57002274 |
46 | MYB_26560356_Chip-Seq_TH2_Human | 1.54169717 |
47 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.53959225 |
48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52062963 |
49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50336551 |
50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.50257369 |
51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49927091 |
52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48429780 |
53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45974985 |
54 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44064134 |
55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43799596 |
56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43221870 |
57 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.43196745 |
58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41859554 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.40203713 |
60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37948573 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36780536 |
62 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35399179 |
63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35233652 |
64 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.26696377 |
65 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25813725 |
66 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25398969 |
67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24323845 |
68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23363826 |
69 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23131594 |
70 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22283072 |
71 | MAF_26560356_Chip-Seq_TH1_Human | 1.21495339 |
72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18476099 |
73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17918411 |
74 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17117570 |
75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16651464 |
76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15991156 |
77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15748818 |
78 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14101501 |
79 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.14080629 |
80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13776931 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13313545 |
82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13242213 |
83 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.13165423 |
84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11721306 |
85 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.10026170 |
86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.09662111 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09424024 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09145076 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06904229 |
90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06478910 |
91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06150221 |
92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05264705 |
93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05187692 |
94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05024641 |
95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04725655 |
96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04170084 |
97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03709092 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02175145 |
99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01877896 |
100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01275274 |
101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01263435 |
102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00867312 |
103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98763454 |
104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97862909 |
105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96160514 |
106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95924583 |
107 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95219641 |
108 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95104815 |
109 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95104815 |
110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94798410 |
111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94616316 |
112 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93452546 |
113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93175315 |
114 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93037705 |
115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92141137 |
116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91975971 |
117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91718783 |
118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90113645 |
119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89953380 |
120 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89084550 |
121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88982058 |
122 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88438363 |
123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87821987 |
124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87522498 |
125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86897944 |
126 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85879795 |
127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85191727 |
128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84630308 |
129 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82960222 |
130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82650919 |
131 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.82113648 |
132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81607004 |
133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81607004 |
134 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81146460 |
135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81023541 |
136 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80881921 |
137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80552053 |
138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80390697 |
139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79157417 |
140 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79152481 |
141 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78890775 |
142 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.78541226 |
143 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.78541226 |
144 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.78541226 |
145 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.78488836 |
146 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77605722 |
147 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.74983367 |
148 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.74096336 |
149 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73431982 |
150 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73067732 |
151 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72157431 |
152 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.71639996 |
153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.71491815 |
154 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70121647 |
155 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69323194 |
156 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.67850505 |
157 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66041428 |
158 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.65903164 |
159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.65787922 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.46793952 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.57128545 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.25300329 |
4 | MP0005365_abnormal_bile_salt | 4.91276693 |
5 | MP0003724_increased_susceptibility_to | 4.73331879 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.26859500 |
7 | MP0003252_abnormal_bile_duct | 3.63835600 |
8 | MP0000678_abnormal_parathyroid_gland | 3.50132263 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.07414441 |
10 | MP0001666_abnormal_nutrient_absorption | 3.00975732 |
11 | MP0010234_abnormal_vibrissa_follicle | 2.90173033 |
12 | MP0009840_abnormal_foam_cell | 2.72738067 |
13 | MP0010329_abnormal_lipoprotein_level | 2.70552058 |
14 | MP0000569_abnormal_digit_pigmentation | 2.65577755 |
15 | MP0001835_abnormal_antigen_presentation | 2.55742781 |
16 | MP0008260_abnormal_autophagy | 2.52873316 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.42491804 |
18 | MP0002419_abnormal_innate_immunity | 2.35614795 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.30485289 |
20 | MP0002009_preneoplasia | 2.23921270 |
21 | MP0003011_delayed_dark_adaptation | 2.15262552 |
22 | MP0004264_abnormal_extraembryonic_tissu | 2.14574949 |
23 | MP0005332_abnormal_amino_acid | 2.13896479 |
24 | MP0003183_abnormal_peptide_metabolism | 2.13841289 |
25 | MP0003828_pulmonary_edema | 2.11249221 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.98047007 |
27 | MP0002138_abnormal_hepatobiliary_system | 1.93538400 |
28 | MP0001800_abnormal_humoral_immune | 1.91126450 |
29 | MP0009785_altered_susceptibility_to | 1.90548534 |
30 | MP0005025_abnormal_response_to | 1.85956690 |
31 | MP0000609_abnormal_liver_physiology | 1.83725726 |
32 | MP0005451_abnormal_body_composition | 1.82172593 |
33 | MP0008057_abnormal_DNA_replication | 1.82063266 |
34 | MP0006082_CNS_inflammation | 1.81504071 |
35 | MP0005000_abnormal_immune_tolerance | 1.80234046 |
36 | MP0002452_abnormal_antigen_presenting | 1.71107285 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.69625299 |
38 | MP0002909_abnormal_adrenal_gland | 1.68832243 |
39 | MP0002723_abnormal_immune_serum | 1.67315194 |
40 | MP0002796_impaired_skin_barrier | 1.66302394 |
41 | MP0002166_altered_tumor_susceptibility | 1.65974658 |
42 | MP0003868_abnormal_feces_composition | 1.65184658 |
43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.64100908 |
44 | MP0003195_calcinosis | 1.63151969 |
45 | MP0010352_gastrointestinal_tract_polyps | 1.61837140 |
46 | MP0002420_abnormal_adaptive_immunity | 1.55050423 |
47 | MP0001819_abnormal_immune_cell | 1.54463657 |
48 | MP0001790_abnormal_immune_system | 1.54319982 |
49 | MP0005387_immune_system_phenotype | 1.54319982 |
50 | MP0005464_abnormal_platelet_physiology | 1.53936509 |
51 | MP0003300_gastrointestinal_ulcer | 1.53109893 |
52 | MP0002118_abnormal_lipid_homeostasis | 1.51245976 |
53 | MP0003690_abnormal_glial_cell | 1.49491661 |
54 | MP0005409_darkened_coat_color | 1.46983254 |
55 | MP0000858_altered_metastatic_potential | 1.45244367 |
56 | MP0001533_abnormal_skeleton_physiology | 1.45182942 |
57 | MP0009643_abnormal_urine_homeostasis | 1.45164865 |
58 | MP0002132_abnormal_respiratory_system | 1.45012896 |
59 | MP0004883_abnormal_blood_vessel | 1.44291088 |
60 | MP0003091_abnormal_cell_migration | 1.38866595 |
61 | MP0000685_abnormal_immune_system | 1.38289813 |
62 | MP0001764_abnormal_homeostasis | 1.38153890 |
63 | MP0005083_abnormal_biliary_tract | 1.35489768 |
64 | MP0004484_altered_response_of | 1.35166864 |
65 | MP0000516_abnormal_urinary_system | 1.33778290 |
66 | MP0005367_renal/urinary_system_phenotyp | 1.33778290 |
67 | MP0005319_abnormal_enzyme/_coenzyme | 1.32487802 |
68 | MP0002405_respiratory_system_inflammati | 1.30456434 |
69 | MP0005164_abnormal_response_to | 1.29695280 |
70 | MP0001845_abnormal_inflammatory_respons | 1.28715307 |
71 | MP0003172_abnormal_lysosome_physiology | 1.27811380 |
72 | MP0002148_abnormal_hypersensitivity_rea | 1.27233403 |
73 | MP0006054_spinal_hemorrhage | 1.25743183 |
74 | MP0004185_abnormal_adipocyte_glucose | 1.18152771 |
75 | MP0000716_abnormal_immune_system | 1.17088918 |
76 | MP0003453_abnormal_keratinocyte_physiol | 1.17062442 |
77 | MP0002998_abnormal_bone_remodeling | 1.15414653 |
78 | MP0002006_tumorigenesis | 1.14938294 |
79 | MP0003075_altered_response_to | 1.14900658 |
80 | MP0002398_abnormal_bone_marrow | 1.14421720 |
81 | MP0005671_abnormal_response_to | 1.14332486 |
82 | MP0001851_eye_inflammation | 1.14307904 |
83 | MP0003763_abnormal_thymus_physiology | 1.13459441 |
84 | MP0004381_abnormal_hair_follicle | 1.13245563 |
85 | MP0002254_reproductive_system_inflammat | 1.12651308 |
86 | MP0003448_altered_tumor_morphology | 1.12392218 |
87 | MP0009278_abnormal_bone_marrow | 1.09773112 |
88 | MP0004043_abnormal_pH_regulation | 1.05526420 |
89 | MP0002396_abnormal_hematopoietic_system | 1.04350703 |
90 | MP0008004_abnormal_stomach_pH | 1.02092658 |
91 | MP0009053_abnormal_anal_canal | 1.01242132 |
92 | MP0003718_maternal_effect | 1.00858920 |
93 | MP0002722_abnormal_immune_system | 1.00640349 |
94 | MP0010678_abnormal_skin_adnexa | 0.99338817 |
95 | MP0005076_abnormal_cell_differentiation | 0.99260336 |
96 | MP0000604_amyloidosis | 0.98561587 |
97 | MP0005647_abnormal_sex_gland | 0.97414037 |
98 | MP0005636_abnormal_mineral_homeostasis | 0.96577758 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96120028 |
100 | MP0001915_intracranial_hemorrhage | 0.96091988 |
101 | MP0000689_abnormal_spleen_morphology | 0.95726415 |
102 | MP0005551_abnormal_eye_electrophysiolog | 0.94567648 |
103 | MP0001545_abnormal_hematopoietic_system | 0.94346825 |
104 | MP0005397_hematopoietic_system_phenotyp | 0.94346825 |
105 | MP0005408_hypopigmentation | 0.94135509 |
106 | MP0005501_abnormal_skin_physiology | 0.93993123 |
107 | MP0003866_abnormal_defecation | 0.92749944 |
108 | MP0000598_abnormal_liver_morphology | 0.92616558 |
109 | MP0001216_abnormal_epidermal_layer | 0.90833792 |
110 | MP0002277_abnormal_respiratory_mucosa | 0.89319975 |
111 | MP0004808_abnormal_hematopoietic_stem | 0.88987431 |
112 | MP0004947_skin_inflammation | 0.87984708 |
113 | MP0009764_decreased_sensitivity_to | 0.87475044 |
114 | MP0002429_abnormal_blood_cell | 0.86978454 |
115 | MP0002136_abnormal_kidney_physiology | 0.86788944 |
116 | MP0005058_abnormal_lysosome_morphology | 0.85926813 |
117 | MP0000703_abnormal_thymus_morphology | 0.82534077 |
118 | MP0010307_abnormal_tumor_latency | 0.81896472 |
119 | MP0001849_ear_inflammation | 0.80715657 |
120 | MP0000015_abnormal_ear_pigmentation | 0.80374614 |
121 | MP0001756_abnormal_urination | 0.80079803 |
122 | MP0000462_abnormal_digestive_system | 0.80076225 |
123 | MP0009333_abnormal_splenocyte_physiolog | 0.77508546 |
124 | MP0003329_amyloid_beta_deposits | 0.77129884 |
125 | MP0000477_abnormal_intestine_morphology | 0.76089942 |
126 | MP0002060_abnormal_skin_morphology | 0.75087219 |
127 | MP0003303_peritoneal_inflammation | 0.73274145 |
128 | MP0005666_abnormal_adipose_tissue | 0.73038866 |
129 | MP0001765_abnormal_ion_homeostasis | 0.71258856 |
130 | MP0008961_abnormal_basal_metabolism | 0.70122625 |
131 | MP0005023_abnormal_wound_healing | 0.68890342 |
132 | MP0000377_abnormal_hair_follicle | 0.68718137 |
133 | MP0010155_abnormal_intestine_physiology | 0.68429741 |
134 | MP0005174_abnormal_tail_pigmentation | 0.68259484 |
135 | MP0005395_other_phenotype | 0.66017456 |
136 | MP0009765_abnormal_xenobiotic_induced | 0.65074741 |
137 | MP0003693_abnormal_embryo_hatching | 0.63253804 |
138 | MP0003186_abnormal_redox_activity | 0.63224001 |
139 | MP0002971_abnormal_brown_adipose | 0.62903790 |
140 | MP0009763_increased_sensitivity_to | 0.62790342 |
141 | MP0005220_abnormal_exocrine_pancreas | 0.62318177 |
142 | MP0009642_abnormal_blood_homeostasis | 0.62270006 |
143 | MP0001873_stomach_inflammation | 0.61764933 |
144 | MP0002098_abnormal_vibrissa_morphology | 0.60929899 |
145 | MP0003656_abnormal_erythrocyte_physiolo | 0.60352105 |
146 | MP0000383_abnormal_hair_follicle | 0.60095352 |
147 | MP0002877_abnormal_melanocyte_morpholog | 0.59871289 |
148 | MP0000579_abnormal_nail_morphology | 0.58657755 |
149 | MP0005376_homeostasis/metabolism_phenot | 0.58638090 |
150 | MP0003566_abnormal_cell_adhesion | 0.58089048 |
151 | MP0005266_abnormal_metabolism | 0.56430414 |
152 | MP0009672_abnormal_birth_weight | 0.56200881 |
153 | MP0008469_abnormal_protein_level | 0.55011313 |
154 | MP0000490_abnormal_crypts_of | 0.55011170 |
155 | MP0003436_decreased_susceptibility_to | 0.54961997 |
156 | MP0005310_abnormal_salivary_gland | 0.54899899 |
157 | MP0000467_abnormal_esophagus_morphology | 0.54425565 |
158 | MP0005167_abnormal_blood-brain_barrier | 0.52353775 |
159 | MP0002078_abnormal_glucose_homeostasis | 0.52080925 |
160 | MP0005248_abnormal_Harderian_gland | 0.51197126 |
161 | MP0000538_abnormal_urinary_bladder | 0.50738388 |
162 | MP0005187_abnormal_penis_morphology | 0.50602081 |
163 | MP0009931_abnormal_skin_appearance | 0.49982274 |
164 | MP0005381_digestive/alimentary_phenotyp | 0.49678290 |
165 | MP0005166_decreased_susceptibility_to | 0.49109551 |
166 | MP0000427_abnormal_hair_cycle | 0.48985868 |
167 | MP0005253_abnormal_eye_physiology | 0.48829673 |
168 | * MP0002086_abnormal_extraembryonic_tissu | 0.48569186 |
169 | MP0008873_increased_physiological_sensi | 0.48089367 |
170 | MP0001730_embryonic_growth_arrest | 0.47810073 |
171 | MP0001663_abnormal_digestive_system | 0.47758330 |
172 | MP0001324_abnormal_eye_pigmentation | 0.45776899 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.49301905 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.94992528 |
3 | Eczematoid dermatitis (HP:0000976) | 5.49724017 |
4 | Deep venous thrombosis (HP:0002625) | 5.42075012 |
5 | Hypobetalipoproteinemia (HP:0003563) | 5.40990937 |
6 | Xanthomatosis (HP:0000991) | 5.09268426 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.94759485 |
8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.94723594 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.82683690 |
10 | Recurrent abscess formation (HP:0002722) | 4.68762174 |
11 | Orchitis (HP:0100796) | 4.49294597 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.32620772 |
13 | Optic neuritis (HP:0100653) | 4.32620772 |
14 | Pigmentary retinal degeneration (HP:0001146) | 4.27055671 |
15 | Tetany (HP:0001281) | 4.25917005 |
16 | Myositis (HP:0100614) | 4.25730024 |
17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13569258 |
18 | Hyperglycinuria (HP:0003108) | 4.06672565 |
19 | Hypolipoproteinemia (HP:0010981) | 4.05426631 |
20 | Fat malabsorption (HP:0002630) | 4.04351299 |
21 | Prolonged partial thromboplastin time (HP:0003645) | 3.91144744 |
22 | Abnormality of macrophages (HP:0004311) | 3.79790457 |
23 | Hyperphosphatemia (HP:0002905) | 3.77249161 |
24 | Epidermoid cyst (HP:0200040) | 3.74902641 |
25 | Complement deficiency (HP:0004431) | 3.74804762 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.73690234 |
27 | Hyperglycinemia (HP:0002154) | 3.65183128 |
28 | Hyperammonemia (HP:0001987) | 3.64725305 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.59948063 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59948063 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.51675713 |
32 | Malnutrition (HP:0004395) | 3.38830689 |
33 | Hypoalphalipoproteinemia (HP:0003233) | 3.37205188 |
34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.36746874 |
35 | Hyperlipoproteinemia (HP:0010980) | 3.34520241 |
36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33874804 |
37 | Keratoconjunctivitis sicca (HP:0001097) | 3.33368684 |
38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33192715 |
39 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.32286693 |
40 | Papillary thyroid carcinoma (HP:0002895) | 3.28985826 |
41 | Hypoglycemic coma (HP:0001325) | 3.23426009 |
42 | Gingivitis (HP:0000230) | 3.22133967 |
43 | Acanthocytosis (HP:0001927) | 3.20675073 |
44 | Ketosis (HP:0001946) | 3.19581401 |
45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.18278484 |
46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17650751 |
47 | Congenital stationary night blindness (HP:0007642) | 3.14128187 |
48 | Gastrointestinal infarctions (HP:0005244) | 3.10145168 |
49 | Abnormality of purine metabolism (HP:0004352) | 3.09879769 |
50 | Subacute progressive viral hepatitis (HP:0006572) | 3.06792322 |
51 | Chorioretinal atrophy (HP:0000533) | 3.01566155 |
52 | Peritonitis (HP:0002586) | 2.98760250 |
53 | Myocardial infarction (HP:0001658) | 2.97846681 |
54 | Recurrent skin infections (HP:0001581) | 2.95760902 |
55 | Spontaneous hematomas (HP:0007420) | 2.94444403 |
56 | Keratoconjunctivitis (HP:0001096) | 2.92588814 |
57 | Mediastinal lymphadenopathy (HP:0100721) | 2.92555010 |
58 | Abnormality of methionine metabolism (HP:0010901) | 2.90784434 |
59 | Abnormality of complement system (HP:0005339) | 2.89412327 |
60 | Hypercholesterolemia (HP:0003124) | 2.88790307 |
61 | Gingival bleeding (HP:0000225) | 2.84442437 |
62 | Gout (HP:0001997) | 2.83668324 |
63 | Joint hemorrhage (HP:0005261) | 2.82431579 |
64 | Arterial thrombosis (HP:0004420) | 2.79027356 |
65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.78633213 |
66 | Increased IgE level (HP:0003212) | 2.77293620 |
67 | Spastic diplegia (HP:0001264) | 2.75295033 |
68 | Amyloidosis (HP:0011034) | 2.69340131 |
69 | Hydroxyprolinuria (HP:0003080) | 2.68283572 |
70 | Abnormality of proline metabolism (HP:0010907) | 2.68283572 |
71 | Stomatitis (HP:0010280) | 2.67870578 |
72 | Steatorrhea (HP:0002570) | 2.65967166 |
73 | Hepatocellular carcinoma (HP:0001402) | 2.60140748 |
74 | T lymphocytopenia (HP:0005403) | 2.60116382 |
75 | Esophageal varix (HP:0002040) | 2.58541034 |
76 | Ketoacidosis (HP:0001993) | 2.55047527 |
77 | Recurrent fungal infections (HP:0002841) | 2.54712127 |
78 | Disinhibition (HP:0000734) | 2.53969359 |
79 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.53224668 |
80 | Cone-rod dystrophy (HP:0000548) | 2.47609779 |
81 | Cellulitis (HP:0100658) | 2.47570714 |
82 | Sensorimotor neuropathy (HP:0007141) | 2.47503788 |
83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44015925 |
84 | Meningitis (HP:0001287) | 2.43196342 |
85 | Abnormality of T cell number (HP:0011839) | 2.37975260 |
86 | Ileus (HP:0002595) | 2.35260456 |
87 | Urticaria (HP:0001025) | 2.33780897 |
88 | Encephalitis (HP:0002383) | 2.30339147 |
89 | Curly hair (HP:0002212) | 2.30142597 |
90 | Vasculitis (HP:0002633) | 2.29548395 |
91 | Hyperbilirubinemia (HP:0002904) | 2.28749522 |
92 | Hypoglycemic seizures (HP:0002173) | 2.28245442 |
93 | Gangrene (HP:0100758) | 2.27062680 |
94 | Polycythemia (HP:0001901) | 2.26712617 |
95 | Viral hepatitis (HP:0006562) | 2.25981330 |
96 | Right ventricular cardiomyopathy (HP:0011663) | 2.24801536 |
97 | Spontaneous abortion (HP:0005268) | 2.19763970 |
98 | Vascular calcification (HP:0004934) | 2.18471898 |
99 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15638261 |
100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15638261 |
101 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.14882279 |
102 | Pulmonary embolism (HP:0002204) | 2.14059719 |
103 | Poikilocytosis (HP:0004447) | 2.13603605 |
104 | Increased purine levels (HP:0004368) | 2.13085746 |
105 | Hyperuricemia (HP:0002149) | 2.13085746 |
106 | Pancreatitis (HP:0001733) | 2.12694729 |
107 | Abnormality of the peritoneum (HP:0002585) | 2.11435038 |
108 | Hypochromic microcytic anemia (HP:0004840) | 2.10126406 |
109 | Metabolic acidosis (HP:0001942) | 2.09562447 |
110 | Chest pain (HP:0100749) | 2.09002702 |
111 | Obstructive lung disease (HP:0006536) | 2.08859591 |
112 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08859591 |
113 | Episodic fever (HP:0001954) | 2.08807817 |
114 | Thickened calvaria (HP:0002684) | 2.08214687 |
115 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08158126 |
116 | Thyroid carcinoma (HP:0002890) | 2.06990806 |
117 | Osteomyelitis (HP:0002754) | 2.06369659 |
118 | Posterior subcapsular cataract (HP:0007787) | 2.04958785 |
119 | Periodontitis (HP:0000704) | 2.04916204 |
120 | Resting tremor (HP:0002322) | 2.04323483 |
121 | Systemic lupus erythematosus (HP:0002725) | 2.02469890 |
122 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01444216 |
123 | Abnormality of serum amino acid levels (HP:0003112) | 2.01237150 |
124 | Autoimmune thrombocytopenia (HP:0001973) | 2.01067535 |
125 | Rickets (HP:0002748) | 2.00323847 |
126 | Hemoptysis (HP:0002105) | 2.00092137 |
127 | Hyperglycemia (HP:0003074) | 1.99095011 |
128 | Abnormality of chloride homeostasis (HP:0011422) | 1.98844263 |
129 | Skin nodule (HP:0200036) | 1.98792883 |
130 | Late onset (HP:0003584) | 1.97438425 |
131 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96976160 |
132 | Syringomyelia (HP:0003396) | 1.96714994 |
133 | Spinal cord lesions (HP:0100561) | 1.96714994 |
134 | Increased CSF protein (HP:0002922) | 1.95194136 |
135 | Delayed CNS myelination (HP:0002188) | 1.93486631 |
136 | Irritability (HP:0000737) | 1.93336872 |
137 | Cholecystitis (HP:0001082) | 1.92674348 |
138 | Abnormal gallbladder physiology (HP:0012438) | 1.92674348 |
139 | Slow saccadic eye movements (HP:0000514) | 1.92639354 |
140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92372262 |
141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91967275 |
142 | Recurrent viral infections (HP:0004429) | 1.90963615 |
143 | Loss of speech (HP:0002371) | 1.89391852 |
144 | Lip pit (HP:0100267) | 1.89042457 |
145 | Nephrolithiasis (HP:0000787) | 1.88450072 |
146 | Thrombophlebitis (HP:0004418) | 1.86760062 |
147 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.85855393 |
148 | Alkalosis (HP:0001948) | 1.85749790 |
149 | Vacuolated lymphocytes (HP:0001922) | 1.85678894 |
150 | Cardiovascular calcification (HP:0011915) | 1.84813264 |
151 | Dyschromatopsia (HP:0007641) | 1.84280738 |
152 | Macular degeneration (HP:0000608) | 1.83577913 |
153 | Confusion (HP:0001289) | 1.83122978 |
154 | Abnormality of the endocardium (HP:0004306) | 1.82054312 |
155 | Pulmonary infiltrates (HP:0002113) | 1.81805715 |
156 | Dehydration (HP:0001944) | 1.81039204 |
157 | Bladder carcinoma (HP:0002862) | 1.80863984 |
158 | Bladder neoplasm (HP:0009725) | 1.80863984 |
159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80760825 |
160 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.79279893 |
161 | Abnormality of vitamin metabolism (HP:0100508) | 1.79020743 |
162 | Subcapsular cataract (HP:0000523) | 1.78915180 |
163 | Vertebral arch anomaly (HP:0008438) | 1.78687935 |
164 | Abnormal cartilage morphology (HP:0002763) | 1.78066749 |
165 | Inflammation of the large intestine (HP:0002037) | 1.77378058 |
166 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77364029 |
167 | Widely patent fontanelles and sutures (HP:0004492) | 1.76781955 |
168 | Biliary tract neoplasm (HP:0100574) | 1.76369094 |
169 | Tetraparesis (HP:0002273) | 1.75826599 |
170 | Epistaxis (HP:0000421) | 1.75144209 |
171 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74928821 |
172 | Leukocytosis (HP:0001974) | 1.74743530 |
173 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73898581 |
174 | Prolonged bleeding time (HP:0003010) | 1.73678809 |
175 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.73501817 |
176 | Symptomatic seizures (HP:0011145) | 1.73179713 |
177 | Anorexia (HP:0002039) | 1.72268640 |
178 | Coarse hair (HP:0002208) | 1.71984481 |
179 | Glomerulopathy (HP:0100820) | 1.69514924 |
180 | Sepsis (HP:0100806) | 1.67474413 |
181 | Interstitial pulmonary disease (HP:0006530) | 1.67422501 |
182 | Decreased motor nerve conduction velocity (HP:0003431) | 1.67120743 |
183 | Gastrointestinal inflammation (HP:0004386) | 1.66097611 |
184 | Hypocalcemia (HP:0002901) | 1.64275969 |
185 | Premature loss of primary teeth (HP:0006323) | 1.63584050 |
186 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.63583254 |
187 | Micronodular cirrhosis (HP:0001413) | 1.63521112 |
188 | Flat acetabular roof (HP:0003180) | 1.61688853 |
189 | Colitis (HP:0002583) | 1.60861763 |
190 | Absent frontal sinuses (HP:0002688) | 1.59727729 |
191 | Menstrual irregularities (HP:0000858) | 1.58785269 |
192 | Termporal pattern (HP:0011008) | 1.57866203 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LATS1 | 4.68459677 |
2 | RIPK4 | 3.45299240 |
3 | FRK | 3.37281382 |
4 | ERN1 | 2.89215887 |
5 | CDK12 | 2.87038422 |
6 | TAOK3 | 2.79749534 |
7 | BLK | 2.75754052 |
8 | IRAK4 | 2.70253498 |
9 | MAP3K14 | 2.56706034 |
10 | MST1R | 2.50563736 |
11 | ERBB4 | 2.45235017 |
12 | STK24 | 2.41313640 |
13 | YES1 | 2.22701272 |
14 | MAP3K10 | 2.17671500 |
15 | PKN2 | 2.12092187 |
16 | STK3 | 2.07048339 |
17 | STK38L | 1.98521572 |
18 | EEF2K | 1.98206981 |
19 | STK10 | 1.94131139 |
20 | BMPR2 | 1.93618468 |
21 | MAP3K2 | 1.83685733 |
22 | EPHA2 | 1.80171901 |
23 | EPHA3 | 1.77929985 |
24 | PRPF4B | 1.74325021 |
25 | FGFR4 | 1.71752080 |
26 | MAP3K3 | 1.71558612 |
27 | GRK1 | 1.70256783 |
28 | PTK6 | 1.70022321 |
29 | TAOK1 | 1.68949222 |
30 | TTK | 1.68472112 |
31 | MAP3K1 | 1.66784246 |
32 | SIK1 | 1.62869337 |
33 | IRAK1 | 1.62671428 |
34 | LATS2 | 1.52434308 |
35 | FGR | 1.50619124 |
36 | KSR1 | 1.47080484 |
37 | TRIB3 | 1.46634767 |
38 | RIPK1 | 1.45708372 |
39 | BRD4 | 1.44126326 |
40 | MST4 | 1.42952405 |
41 | BCKDK | 1.40860809 |
42 | IRAK2 | 1.40538477 |
43 | GRK6 | 1.40340426 |
44 | AKT3 | 1.39588108 |
45 | TYK2 | 1.38234261 |
46 | KSR2 | 1.33411509 |
47 | MAP3K13 | 1.32950725 |
48 | ZAP70 | 1.32709087 |
49 | IKBKE | 1.28975250 |
50 | NEK2 | 1.27427982 |
51 | CDK6 | 1.24327043 |
52 | MET | 1.23041272 |
53 | MAPK11 | 1.20142125 |
54 | WNK1 | 1.19214786 |
55 | HCK | 1.15558746 |
56 | FES | 1.13179905 |
57 | JAK3 | 1.12411990 |
58 | SIK3 | 1.10566593 |
59 | BTK | 1.09975861 |
60 | MATK | 1.07015759 |
61 | JAK2 | 1.03532893 |
62 | MAP3K8 | 0.99801502 |
63 | SGK2 | 0.99511663 |
64 | PRKAA2 | 0.98088676 |
65 | MAP3K6 | 0.98046227 |
66 | INSRR | 0.97471694 |
67 | MAP4K1 | 0.95835150 |
68 | MAP3K9 | 0.94696637 |
69 | MAPKAPK3 | 0.93902328 |
70 | NEK6 | 0.90951759 |
71 | RPS6KB2 | 0.88962779 |
72 | MELK | 0.86530225 |
73 | ACVR1B | 0.86413914 |
74 | PDK2 | 0.84038305 |
75 | MTOR | 0.83932838 |
76 | SYK | 0.83899788 |
77 | SCYL2 | 0.83489280 |
78 | PIK3CG | 0.83197670 |
79 | PRKAA1 | 0.82315366 |
80 | DMPK | 0.81365439 |
81 | CDK4 | 0.81071475 |
82 | MAP2K3 | 0.80335702 |
83 | LYN | 0.78354316 |
84 | MAPK7 | 0.77847770 |
85 | NLK | 0.77173688 |
86 | CDK9 | 0.77151566 |
87 | LRRK2 | 0.76869874 |
88 | ABL2 | 0.76710554 |
89 | CAMKK2 | 0.75488795 |
90 | CSF1R | 0.74170569 |
91 | MARK2 | 0.73700459 |
92 | CDC7 | 0.72526583 |
93 | CAMK1D | 0.71597787 |
94 | FLT3 | 0.70553367 |
95 | MAP3K12 | 0.69610086 |
96 | MAP3K7 | 0.69061446 |
97 | GSK3A | 0.66720005 |
98 | RPS6KA4 | 0.66301793 |
99 | MAP2K2 | 0.65820197 |
100 | LMTK2 | 0.65286837 |
101 | WNK3 | 0.64852818 |
102 | NUAK1 | 0.64324215 |
103 | SGK3 | 0.63636861 |
104 | BMX | 0.63229065 |
105 | JAK1 | 0.60968599 |
106 | DYRK3 | 0.60685331 |
107 | TBK1 | 0.60669563 |
108 | TEC | 0.60584647 |
109 | CHEK2 | 0.60288023 |
110 | PIM1 | 0.58491453 |
111 | ERBB2 | 0.58356575 |
112 | PDGFRB | 0.56572690 |
113 | LCK | 0.56048936 |
114 | PTK2 | 0.55450809 |
115 | AURKB | 0.54707056 |
116 | MOS | 0.54613111 |
117 | SMG1 | 0.54379120 |
118 | FGFR3 | 0.54295177 |
119 | ERBB3 | 0.54085634 |
120 | PDPK1 | 0.53903049 |
121 | RET | 0.51389538 |
122 | PDK1 | 0.50560050 |
123 | STK38 | 0.50217233 |
124 | SIK2 | 0.49195771 |
125 | FYN | 0.48848587 |
126 | PRKCI | 0.47765354 |
127 | SGK494 | 0.47385837 |
128 | SGK223 | 0.47385837 |
129 | DYRK1B | 0.47353897 |
130 | CDK7 | 0.47303335 |
131 | MAP3K5 | 0.47105955 |
132 | CSNK1D | 0.46557860 |
133 | BCR | 0.46468250 |
134 | PDGFRA | 0.44282771 |
135 | ITK | 0.44268043 |
136 | FGFR2 | 0.44078908 |
137 | STK4 | 0.44028801 |
138 | ICK | 0.43554473 |
139 | STK11 | 0.43436163 |
140 | NEK9 | 0.42827996 |
141 | EPHB1 | 0.42122254 |
142 | AKT2 | 0.41634426 |
143 | NEK1 | 0.39693977 |
144 | PBK | 0.39689586 |
145 | TGFBR2 | 0.38985551 |
146 | ABL1 | 0.38368341 |
147 | PDK3 | 0.38344924 |
148 | PDK4 | 0.38344924 |
149 | MAP2K4 | 0.36821042 |
150 | FER | 0.36782293 |
151 | RAF1 | 0.34787885 |
152 | CSK | 0.34329806 |
153 | PRKG2 | 0.33437184 |
154 | CHEK1 | 0.32397812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77088100 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57401855 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54890854 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08360304 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.70458414 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49310178 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30728328 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29797313 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27050763 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23098006 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15181457 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14436446 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07281388 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01752122 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01375821 |
16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97438122 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94405669 |
18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92495214 |
19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92222310 |
20 | Bile secretion_Homo sapiens_hsa04976 | 1.90928567 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90699346 |
22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90233452 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87744623 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.83492299 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76726920 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.74275561 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69999167 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69744403 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67543344 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64569667 |
31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64090591 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.61566314 |
33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60610788 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60591124 |
35 | Peroxisome_Homo sapiens_hsa04146 | 1.60325727 |
36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60190547 |
37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59205755 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59155601 |
39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57759101 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56287314 |
41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55282453 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55102216 |
43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.53996174 |
44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53758115 |
45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.53380851 |
46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53054840 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.52728584 |
48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51426313 |
49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47488045 |
50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46134204 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42076021 |
52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40690950 |
53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40264359 |
54 | Measles_Homo sapiens_hsa05162 | 1.39638356 |
55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38982176 |
56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38959184 |
57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35209065 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35003776 |
59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34929532 |
60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34620008 |
61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34123513 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32751705 |
63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31637209 |
64 | Influenza A_Homo sapiens_hsa05164 | 1.31299177 |
65 | ABC transporters_Homo sapiens_hsa02010 | 1.31039607 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 1.30321320 |
67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30217756 |
68 | Endometrial cancer_Homo sapiens_hsa05213 | 1.27774544 |
69 | Hepatitis B_Homo sapiens_hsa05161 | 1.26401375 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.25882970 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25090549 |
72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24956111 |
73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24302713 |
74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23625398 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22640421 |
76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18924972 |
77 | Malaria_Homo sapiens_hsa05144 | 1.18066080 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16245758 |
79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13668383 |
80 | Platelet activation_Homo sapiens_hsa04611 | 1.09609911 |
81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09402021 |
82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07534061 |
83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05985204 |
84 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04064949 |
85 | Phagosome_Homo sapiens_hsa04145 | 1.03850880 |
86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01797038 |
87 | Salmonella infection_Homo sapiens_hsa05132 | 1.01072477 |
88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00636867 |
89 | Apoptosis_Homo sapiens_hsa04210 | 0.99395977 |
90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98840250 |
91 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97590188 |
92 | Pertussis_Homo sapiens_hsa05133 | 0.97333394 |
93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96412435 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94795671 |
95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94421077 |
96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93634366 |
97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93473373 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93281144 |
99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92034740 |
100 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90607956 |
101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88797808 |
102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87268112 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85380700 |
104 | Prostate cancer_Homo sapiens_hsa05215 | 0.85276547 |
105 | Mineral absorption_Homo sapiens_hsa04978 | 0.85072316 |
106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83279451 |
107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82755840 |
108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82510428 |
109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81738818 |
110 | Shigellosis_Homo sapiens_hsa05131 | 0.81455833 |
111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80817971 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77419517 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76757053 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76689863 |
115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72216785 |
116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68684467 |
117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66161780 |
118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66008491 |
119 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65797424 |
120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65063733 |
121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64808740 |
122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64375378 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64365087 |
124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64324697 |
125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63997618 |
126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63069147 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.62976742 |
128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62625619 |
129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62327113 |
130 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62070055 |
131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60614445 |
132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60560944 |
133 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59686806 |
134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58758366 |
135 | Lysosome_Homo sapiens_hsa04142 | 0.58587237 |
136 | Glioma_Homo sapiens_hsa05214 | 0.57548670 |
137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57301368 |
138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56522595 |
139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54939000 |
140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51999464 |
141 | Long-term depression_Homo sapiens_hsa04730 | 0.51215673 |
142 | Insulin resistance_Homo sapiens_hsa04931 | 0.49997017 |
143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49002813 |
144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47975734 |
145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47255093 |
146 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46862163 |
147 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46412600 |
148 | Allograft rejection_Homo sapiens_hsa05330 | 0.46253985 |
149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42805125 |
150 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41851814 |
151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41433780 |
152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35996847 |
153 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33800207 |
154 | Bladder cancer_Homo sapiens_hsa05219 | 0.29393172 |
155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24804948 |
156 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.24230369 |
157 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23135655 |
158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.21340922 |
159 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19369560 |
160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19220449 |
161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15306058 |
162 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.14814289 |
163 | Hepatitis C_Homo sapiens_hsa05160 | 0.14687446 |
164 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14461413 |
165 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12551667 |
166 | Adherens junction_Homo sapiens_hsa04520 | 0.11980901 |
167 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11913518 |
168 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09734080 |
169 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09715797 |
170 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08888133 |
171 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06037003 |
172 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05063591 |
173 | Amoebiasis_Homo sapiens_hsa05146 | 0.03768953 |
174 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.03139501 |
175 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.02884780 |
176 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02558234 |
177 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01021471 |
178 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.00904162 |